| Metric | Q3 2021 | Q2 2021 | Q3 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.9B | — | — | — | — |
| Op. Income | $175M | — | — | — | — |
| Gross Margin | 10.9% | — | — | — | — |
| Net Margin | 4.5% | — | — | — | — |
| EPS (Diluted) | $0.83 | — | — | — | — |
| Free Cash Flow | $77M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $1.9B |
| Cost of Revenue | $1.7B |
| GROSS PROFIT | $206M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $30M |
| Other Expenses | $1M |
| Operating Expenses | $31M |
| Cost & Expenses | $1.7B |
| OPERATING INCOME | $175M |
| Interest Income | $0 |
| Interest Expense | $23M |
| Other Income/Expenses | -$22M |
| INCOME BEFORE TAX | $153M |
| Income Tax Expense | $47M |
| Net Income from Continuing Ops | $106M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $84M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $84M |
| D&A | $67M |
| EBIT | $176M |
| EBITDA | $243M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $1.9B |
| Cost of Revenue | $1.7B |
| GROSS PROFIT | $206M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $30M |
| Other Expenses | $1M |
| Operating Expenses | $31M |
| Cost & Expenses | $1.7B |
| OPERATING INCOME | $175M |
| Interest Income | $0 |
| Interest Expense | $23M |
| Other Income/Expenses | -$22M |
| INCOME BEFORE TAX | $153M |
| Income Tax Expense | $47M |
| Net Income from Continuing Ops | $106M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $84M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $84M |
| D&A | $67M |
| EBIT | $176M |
| EBITDA | $243M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $84M |
| Depreciation & Amortization | $67M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $68M |
| Other Non-Cash Items | $35M |
| Change in Working Capital | -$115M |
| OPERATING CASH FLOW | $139M |
| Capital Expenditure | -$62M |
| Acquisitions (Net) | $1M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$2M |
| NET CASH FROM INVESTING | -$63M |
| Net Debt Issuance | -$15M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$14M |
| NET CASH FROM FINANCING | -$29M |
| FREE CASH FLOW | $77M |
| Net Change in Cash | $47M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $573M |
| Short-Term Investments | $4M |
| Net Receivables | $240M |
| Inventory | $422M |
| Other Current Assets | $65M |
| TOTAL CURRENT ASSETS | $1.3B |
| PP&E (Net) | $2.3B |
| Goodwill | $0 |
| Intangible Assets | $3M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $236M |
| TOTAL NON-CURRENT ASSETS | $2.6B |
| TOTAL ASSETS | $3.9B |
| Account Payables | $409M |
| Short-Term Debt | $18M |
| Deferred Revenue | $34M |
| Other Current Liabilities | $513M |
| TOTAL CURRENT LIABILITIES | $1.0B |
| Long-Term Debt | $1.6B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $333M |
| Other Non-Current Liabilities | $43M |
| TOTAL NON-CURRENT LIABILITIES | $2.1B |
| TOTAL LIABILITIES | $3.1B |
| Common Stock | $1M |
| Additional Paid-In Capital | $1.5B |
| Retained Earnings | -$942M |
| Treasury Stock | -$2M |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $567M |
| Minority Interest | $198M |
| TOTAL EQUITY | $765M |
| TOTAL LIABILITIES & EQUITY | $3.9B |
| Total Debt | $1.7B |
| Net Debt | $1.1B |
